FWT Homepage Translator

Recent News

Patients with sleep apnea who are intolerant of traditional therapy such as CPAP or those who have failed other treatment modalities may be candidates for the Inspire hypoglossal nerve stimulator. This device is similar to a pacemaker. A device is implanted in the chest that detects pauses in breathing and provides stimulation to the tongue muscle, preventing it from falling back and blocking the air passage. This device has been approved by the FDA and thousands of patients have undergone this surgery around the world. St. Joseph Mercy Health System is one of three hospitals in the Michigan performing this surgery. In order to be a candidate, patients must have body mass index (BMI) of 32 or less and have moderate to severe sleep apnea. In addition, patients considering this procedure will need to undergo a sleep endoscopy (DISE) to establish candidacy. The inspire device has cure rates of over 50% with more than 70% of patients able to discontinue CPAP. Snoring resolves in over 85% of patients. Better yet, 85% of patients continue to use the device after 3 years. For more information go to

  • Predictors of surgical success for patients undergoing TORS for OSA. European obstructive sleep apnea Society meeting. Rimini, Italy. September 2016
  • Sleep apnea in the aging population. Bangkok Thailand. March 3 2015
  • Snorers: Robotic surgery deemed safe. Can it help? - By Robin Erb, Detroit Free Press
  • Dr. Hoff has recently completed an instructional video for new robotic surgeon interested in removal of benign tissue from the base of tongue. This technique has specific application in the treatment of obstructive sleep apnea. Anticipate release of the video in late April in time for the Head and Neck Society Meeting in Boston.
  • Dr. Hoff has been appointed as an Assistant Professor of Otolaryngology Head and Neck Surgery at the University of Michigan. He will maintain practices at both St. Joseph Mercy Health System and the University of Michigan.
  • St. Joseph Mercy Ann Arbor leads new FDA- approved robotic surgery that helps treat sleep apnea